Previous Nav
Net Change on 26-05-2023
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Divi's Laboratories Ltd.
Dr. Reddy's Laboratories Ltd.
Cipla Ltd.
Apollo Hospitals Enterprise Ltd.
JB Chemicals & Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd.
Alkem Laboratories Ltd.
Abbott India Ltd.
Syngene International Ltd.
IPCA Laboratories Ltd.
Zydus Lifesciences Ltd.
Vinati Organics Ltd.
Aster DM Healthcare Ltd.
Laurus Labs Ltd.
Pfizer Ltd.
TREPS
Gland Pharma Ltd.
Jubilant Ingrevia Ltd.
Rossari Biotech Ltd.
HDFC Life Insurance Company Ltd.
ICICI Lombard General Insurance Company Ltd.
Indoco Remedies Ltd.
Natco Pharma Ltd.
Net Receivable / Payable
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Chemicals
Miscellaneous
Insurance
Cash
Equity
IDBI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to IDBI Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹51.46 crore. IDBI Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.
The NAV of IDBI Healthcare Fund ended up ₹0.17(0.98%)yesterday to ₹17.55.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The IDBI Healthcare Fund is managed by Alok Ranjan .
5th floor, Mafatlal Centre, Nariman Point Mumbai - 400021